Woman Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The purpose of this study is to determine the safety and tolerability of rebastinib when combined with antitubulin therapy with paclitaxel or eribulin in patients with advanced breast cancer.
Inclusion criteria
- Breast Cancer,Breast Adenocarcinoma,Human Epidermal Growth Factor 2 Negative Carcinoma of Breast,Recurrent Breast Carcinoma,Stage IV Breast Cancer